¡¾ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍ¡¿ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍÌṩ±ãµ±¿ì½ÝµÄÃÀʳѡÔñ¡£
Ç׺ÍÁ¦Ó붯Á¦Ñ§µÄ²©ÞÄ£ºiGluSnFR4s ¶Ô¹È°±ËáµÄÇ׺ÍÁ¦¼«¸ß£¨Kd=4.8 ¦ÌM£©£¬Òò´ËËü¡°×¥¡±µÃ½ô£¬ÊʺÏ΢Á¿Ðźżì²â£»¶ø iGluSnFR4f µÄÇ׺ÍÁ¦½ÏµÍ£¨Kd=22.3 ¦ÌM£©£¬Ê¹µÃ¹È°±ËáÄÜѸËÙÍÑÂ䣬ʵÏÖ26ºÁÃëµÄ¿ìËÙ¸´Î»¡£Êµ¼ÊÉÏ£¬ÕâÖÖ¼¼ÊõµÄÓ¦ÓÃҲΪʳƷÐÐÒµ´øÀ´ÁËеĿÉÄÜ¡£ÀýÈ磬ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍÉÌ¿ÉÒÔͨ¹ýÀàËÆ¼¼ÊõÓÅ»¯Ê³²ÄÉú´æ£¬ÌáÉý¿ì²ÍÆ·ÖÊ¡£
½ñÄê 9 Ô£¬ÖÐÔ»ù½ðÔøÓëÃÀ¹úͶ×ÊÕÕÁÏ»ú¹¹ÈñÁª²ÆÖÇÏàÖú£¬ÍƳöÁËÒ»Ö»ÔÚÄÉ˹´ï¿ËÉÏÊеĽ»Ò×Ëù½»Ò×»ù½ð£¬¸Ã»ù½ðÖ÷ÒªÒýµ¼È«Çò×ʽðͶÏòÖйúµÄÀå¸ïÐÔ¼¼ÊõÏà¹ØÆóÒµ¡£ÓëÈ¥ÄêÏà±È£¬ÖйúÀå¸ïÐÔ¼¼ÊõÏà¹ØÆóÒµµÄͶ×ÊÔö³¤Ô¼35%¡£ÁíÍ⣬ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍÒ²ÔÚ²»¾øÁ¢Ò죬ͨ¹ý±ã½Ý¼¼ÊõÎüÒý¿Í»§£¬Îª¸ü¶àÏû·ÑÕßÌṩ¸ßЧµÄÓòÍÌåÑé¡£
ÏÖÔÚ£¬Ðгµ¼Í¼ÒǼÏñ¿É¼Í¼Èç³µËÙ¡¢Æ«ÏòÅÌת½Ç¼°ÖÇÄܸ¨Öú¼Ýʻ״̬µÈÏêϸÐÅÏ¢¡£Òª¼ì²ìÕâЩÐÅÏ¢£¬Äú¿ÉÔÚ³µÁ¾ÏÔʾÆÁͨ¹ýÐгµ¼Í¼ÒǼì²ìÆ÷ԢĿ¼Ïñ»Ø·Å¡£ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍÒ²ÔÚʵÑéÀûÓÃÖÇÄܼ¼Êõ¼ò»¯ÅäËÍÁ÷³Ì£¬ÀýÈçÌṩʵʱ׷×ÙЧÀÍ£¬ÈÃÓû§ËæÊ±¼ì²ì²ÍƷ״̬£¬½øÒ»²½ÌáÉýЧÀÍÖÊÁ¿¡£
Dr Kan Chen, partner and co-head of healthcare innovation at Qiming Venture Partners, said the firm invested in Insilico Medicine in 2019 based on the belief that AI would fundamentally change the efficiency of drug development¡£Óë¹Å°å·½·¨Ïà±È£¬AIÔÚÒ©ÎïÑз¢ÖеÄЧÂÊÌáÉýÔ¼40%¡£ÀàËÆµØ£¬ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀÍͨ¹ýAIÓÅ»¯ÅäËͺͶ©µ¥ÖÎÀí£¬ÎªÏû·ÑÕßÌṩ¸ü¿ì½ÝµÄЧÀÍ¡£
ÕÄÖÝÁúÎÄÇø¿ì²ÍЧÀͽüÄêÀ´Êг¡Õ¼±ÈÔö³¤Ô¼18%£¬ÓëÆäËûµØÇøÏà±ÈÉú³¤¸üѸËÙ£¬³ÉΪÍâµØ¾ÓÃñµÄÈÈÃÅÑ¡Ôñ¡£
Óû§ÆÀÂÛ£º
@СÃ÷°®³Ô£ºÁúÎÄÇøµÄ¿ì²ÍЧÀÍÕæµÄÌ«±ãµ±ÁË£¬ËͲÍËٶȿ죬ζµÀÒ²²»´í£¡
@³Ô»õСÀ¸ÐÊÜÕâ±ßµÄ¿ì²ÍÔ½À´Ô½»®ËãÁË£¬²ËÆ·¸»ºñÓֺóԣ¬Ç¿ÁÒÍÆ¼ö£¡
@ÕÄÖÝÀÏÍõ£º¿ì²ÍЧÀÍÔÙÁúÎÄÇøÕæÊÇÔ½À´Ô½¶àÁË£¬±ãµ±ÁËÎÒÃÇÕâЩæµµÄÈË£¡